XML 68 R55.htm IDEA: XBRL DOCUMENT v3.22.0.1

Derivatives (Tables)

12 Months Ended

Dec. 31, 2021

Derivatives

Schedule of effect of derivative instruments on consolidated financial position

​

​	​	​	​	​	​	​
​	​	December 31,
(in thousands)	​	2021		​	​	2020
Interest rate swaps designated as cash flow hedging instruments	​	​	​	​	​	​
Accrued liabilities	​	$	727	​	$	4,810
Other liabilities	​		—	​		1,527
Total derivatives designated as cash flow hedging instruments	​	​	727	​	​	6,337
​	​	​	​	​	​	​
Interest rate swaps not designated as hedging instruments	​	​	​	​	​	​
Accrued liabilities	​	​	523	​	​	—
​	​	​	​	​	​	​
Total derivative liabilities	​	$	1,250	​	$	6,337

Schedule of effect of derivative instruments on results of operations

​

​	​	​	​	​	​	​	​	​	​
​	​	Year Ended December 31,
(in thousands)	​	2021			2020			2019
Total amount of interest expense in which the effects of cash flow hedges and undesignated interest rate swaps are recorded	​	$	108,135	​	$	105,716	​	$	104,681
​	​	​	​	​	​	​	​	​	​
Interest rate swaps designated as cash flow hedging instruments	​	​	​	​	​	​	​	​	​
Pre-tax loss recognized in other comprehensive income (loss)	​	$	(1,219)	​	$	(8,459)	​	$	(6,785)
Pre-tax gain (loss) reclassified from accumulated other comprehensive income (loss) into interest expense	​		(6,308)	​		(3,878)	​		2,278
​	​	​	​	​	​	​	​	​	​
Interest rate swaps not designated as hedging instruments	​	​	​	​	​	​	​	​	​
Gain recognized in interest expense	​	$	1,088	​	$	—	​	$	—

X

- References

No definition available.

+ Details

Name:	us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4E
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4A
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4B
-URI http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959

+ Details

Name:	us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration